Learn / KRYS
NASDAQ: KRYS
Krystal Biotech (KRYS) stock, explained like you're 5
Krystal Biotech trades on the Nasdaq under the ticker KRYS. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 9.8 billion dollars.
- Ticker
- KRYS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 9.8 billion dollars
Is Krystal Biotech a small, medium or large cap company?
No. Krystal Biotech is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 9.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Krystal Biotech makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves KRYS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome (Yahoo Finance)
- Krystal Biotech (KRYS) Posts Strong KB113 Data, Is The Stock Fully Priced? (Simply Wall Street)
- Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $395.44, Implies 20% Upside (TradingView)
- Insiders At Krystal Biotech Sold US$54m In Stock, Alluding To Potential Weakness (Moomoo)
- An experimental skin cancer treatment shrank some tumors doctors didn't inject. Three patients were studied. (Stock Titan)
Follow KRYS in your daily brief
Each trading day at 5 PM ET we post what happened to Krystal Biotech and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow KRYS
Questions about Krystal Biotech stock
What does Krystal Biotech do?
Krystal Biotech trades on the Nasdaq under the ticker KRYS. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 9.8 billion dollars.
What is the ticker symbol for Krystal Biotech?
Krystal Biotech trades under the ticker KRYS on the Nasdaq.
What is Krystal Biotech's market cap?
Krystal Biotech is a mid cap stock with a market cap of about 9.8 billion dollars.
How does Krystal Biotech make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves KRYS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow KRYS stock every day?
Add KRYS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.